Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2016
A short history of neuroendocrine tumours and their peptide hormonesWouter W de Herder, Jens F Rehfeld, Mark Kidd, et al.
Cancer|November 1, 2005
The molecular genetics of gastroenteropancreatic neuroendocrine tumorsMichelle N Zikusoka, Mark Kidd, Geeta Eick, et al.
The American Journal of Gastroenterology|March 30, 2007
A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progressIrvin M Modlin, Manish C Champaneria, Anthony K C Chan, et al.
Virchows Archiv : an International Journal of Pathology|August 9, 2007
Siegfried Oberndorfer: a tribute to his work and life between Munich, Kiel, Geneva, and IstanbulGünter Klöppel, Katherine Dege, Wolfgang Remmele, et al.
Neuroendocrinology|April 15, 2016
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes ProgressiveMarianne Pavel, Henning Jann, Vikas Prasad, et al.
Seminars in Nuclear Medicine|April 13, 2016
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic CancerLisa Bodei, Dik J Kwekkeboom, Mark Kidd, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2006
The functional characterization of normal and neoplastic human enterochromaffin cellsIrvin M Modlin, Mark Kidd, Roswitha Pfragner, et al.
Neuroendocrinology|October 11, 2014
Neuroendocrine tumor biomarkers: current status and perspectivesIrvin M Modlin, Kjell Oberg, Andrew Taylor, et al.
Cancer|March 10, 2011
Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKTBernhard Svejda, Mark Kidd, Alexander Kazberouk, et al.
Medical Molecular Morphology|June 22, 2012
Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidineReidar Alexander Vigen, Mark Kidd, Irvin M Modlin, et al.
Pageof 22